S. Webber

发表

Developing a RationalTumorVaccineTherapy for Renal Cell Carcinoma: ImmuneYin andYang

A. Schned, T. Crocenzi, J. Fisher, 2007 .

Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients

A. Schned, T. Crocenzi, J. Fisher, 2009, Clinical Cancer Research.

Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-dendritic Cell Vaccine with Aldesleukin (interleukin 2) and Ifn-α2a Therapy in Metastatic Renal Cell Carcinoma Patients Section of Urology, Departments Of

A. Schned, T. Crocenzi, J. Fisher, 2022 .

Developing a Rational Tumor Vaccine Therapy for Renal Cell Carcinoma: Immune Yin and Yang

A. Schned, T. Crocenzi, J. Fisher, 2007, Clinical Cancer Research.

Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.

A. Barber, Z. Szczepiorkowski, K. Meehan, 2008, Cytotherapy.

Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization

Z. Szczepiorkowski, K. Meehan, P. Ely, 2006, Transfusion.

Immune Mobilization with Direct In-Vivo Effector Response: Clinical Trial with Favorable Implications for Post-Transplant Outcome.

M. Ernstoff, Z. Szczepiorkowski, K. Meehan, 2007 .

Adsorption Filtration of Leukocyte‐Reduced Single Donor Platelet Units

J. AuBuchon, S. Webber, A. Burbank, 1994, Vox sanguinis.